Effect of Imatinib on Bone Metabolism in Patients With Chronic Myelogenous Leukemia or Gastrointestinal Stromal Tumors

NACompletedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

November 30, 2006

Primary Completion Date

October 31, 2013

Study Completion Date

October 31, 2013

Conditions
Gastric CancerLeukemiaChronic Myelogenous Leukemia
Interventions
OTHER

blood test, urine test, and bone density x-ray.

start of the study (month 0), and at months 3, 6, 9, 12 (1 year), 15, 18, 21, and 24 (2 years)

Trial Locations (1)

10065

Memorial Sloan-Kettering Cancer Center, New York

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Novartis

INDUSTRY

lead

Memorial Sloan Kettering Cancer Center

OTHER